Targeted Therapy of DNA Tumor Virus-Associated Cancers Using Virus-Activated Transcription Factors
Open Access
- 31 May 2006
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 13 (5) , 899-909
- https://doi.org/10.1016/j.ymthe.2005.11.023
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Oncolytic viruses for the treatment of cancer: current strategies and clinical trialsDrug Discovery Today, 2004
- The role of TP53 in Cervical carcinogenesisHuman Mutation, 2003
- Epstein-Barr Virus (EBV) and lymphomagenesisFrontiers in Bioscience-Landmark, 2002
- Ras Induces Elevation of E2F-1 mRNA LevelsJournal of Biological Chemistry, 2001
- Ras Inactivation of the Retinoblastoma Pathway by Distinct Mechanisms in NIH 3T3 Fibroblast and RIE-1 Epithelial CellsJournal of Biological Chemistry, 2000
- Rapid Progression of Primary Vaginal Squamous Cell Carcinoma in a Young HIV-Infected WomanGynecologic Oncology, 2000
- Control of E2F activity by p21Waf1/Cip1Oncogene, 1999
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factorNature, 1991
- Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.Proceedings of the National Academy of Sciences, 1988